Psychological features of adult patients with langerhans cell histiocytosis
Open Access
- 12 February 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (2), e0246604
- https://doi.org/10.1371/journal.pone.0246604
Abstract
The prevalence of psychological symptoms and the co-occurrence of substance abuse disorders in adult patients with Langerhans cell histiocytosis (LCH) has not been previously explored. We aimed to use validated scales to evaluate depression and anxiety symptoms experienced by adult LCH patients. In this cross-sectional study, all consecutive adult LCH patients seen at our national reference center between January 2012 and January 2013 were asked to complete the following instruments: the Hospital Anxiety and Depression scale (HADS); Barratt Impulsiveness Scale, Version 10 (BIS-10); and Cannabis Use Disorders Identification Test (CUDIT). Self-reported scores on these scales were used to determine the point prevalence of clinically significant psychological symptoms and substance use disorders in LCH patients. Patient profiles in terms of psychological features were assessed by principal component analysis including the HADS and BIS-10 instruments values, followed by hierarchical clustering. Fisher exact tests and Wilcoxon tests were used to examine the associations between disease-related parameters and high levels of anxiety and impulsivity. Seventy-one adult LCH patients, mainly with pulmonary LCH (PLCH), completed the evaluations. Clinically significant anxiety and depression symptoms were reported by 22 (31%) and 4 (6%) subjects, respectively. Impulsivity was detected in 14% (10/71) of the patients. Seventeen percent (12/71) of the patients used cannabis on a regular basis, with 50% of these individuals (6/12) exhibiting scores consistent with cannabis use disorder. Three derived clusters of patients were identified in the principal component analysis; these patient clusters differed in successful weaning from tobacco at the time of evaluation (p = 0.03). In univariate analyses, isolated PLCH and the use of psychotropic treatments were statistically associated with clinically significant anxiety symptoms. High levels of anxiety and impulsivity are common in adult patients with LCH. The consequences of these symptoms for the management of LCH patients warrant further evaluation.This publication has 48 references indexed in Scilit:
- Recurrent BRAF mutations in Langerhans cell histiocytosisBlood, 2010
- Health‐related quality of life, cognitive functioning and behaviour problems in children with Langerhans cell histiocytosisPediatric Blood & Cancer, 2008
- Skeletal Langerhans cell histiocytosis in children: Permanent consequences and health‐related quality of life in long‐term survivorsPediatric Blood & Cancer, 2008
- Long term morbidity and health related quality of life after multi-system Langerhans cell histiocytosisEuropean Journal of Cancer, 2006
- Pulmonary abnormalities at long-term follow-up of patients with Langerhans cell histiocytosisMedical and Pediatric Oncology, 2001
- Factor structure of the barratt impulsiveness scaleJournal of Clinical Psychology, 1995
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983
- Open Biopsy for Chronic Diffuse Infiltrative Lung Disease: Clinical, Roentgenographic, and Physiological Correlations in 502 PatientsThe Annals of Thoracic Surgery, 1980
- An index of factorial simplicityPsychometrika, 1974
- Measures of multivariate skewness and kurtosis with applicationsBiometrika, 1970